New-onset trichotillomania during treatment with stimulant drugs. About two pediatric clinical cases

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Stimulant drugs are commonly used in pediatric population in the treatment of attention deficit hyperactivity disorder, and their side effects are well described, however trichotillomania does not appear as one of them. In the literature we found some published cases of trichotillomania in relation to methylphenidate and dextroamphetamine. We present two cases of new-onset trichotillomania in children followed up in our center by attention deficit hyperactivity disorder and treated with psychostimulant drugs (methylphenidate and lisdexamfetamine), as a probable adverse effect of this treatment.

Cite

CITATION STYLE

APA

Manso, B. F., Morcillo, N. V., Taboas Pereira, M. A., & Maldonado, C. E. (2020). New-onset trichotillomania during treatment with stimulant drugs. About two pediatric clinical cases. Archivos Argentinos de Pediatria, 118(1), E61–E62. https://doi.org/10.5546/AAP.2020.E61

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free